COSCIENS Biopharma Inc (CSCI)

[cary73]

so, there is only 1 phase three study and the macrilen has only 1 use as a test the text is just words ... the problem is that there is no trust in management and investors see no value here and the share price shows it .... even if in 2023 they approved this test for adolescents, a test would always be and would not lead to large cash inflows.
they have not been able to market the test in Europe and England for 4 years ... but it's okay ... so the salary always comes and they can do shit with ice buckets ....
This is aezs the only hope here is that a decent pr on the covid pill will come out and come out at no loss ....